Optiver Holding
TELA icon

Optiver Holding’s TELA Bio TELA Stock Holding History

Optiver Holding’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,035
Closed -$55K – 850
2021
Q4 		$55K Hold
4,035
– – ﹤0.01% 403
2021
Q3 		$55K Hold
4,035
– – ﹤0.01% 318
2021
Q2 		$65K Buy
+4,035
New +$55.3K ﹤0.01% 269

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Optiver Holding's TELA Position: Q1 2022 in Review

Optiver Holding sold out of TELA Bio (TELA) in Q1 2022, closing a stake of 4,035 shares — an estimated $55K sold.

Optiver Holding first reported a position in TELA in Q2 2021 and held it in 3 quarters. The position peaked at $65K in Q2 2021. 30 funds tracked by Wall St. Rank hold TELA as of Q1 2022.

  • Optiver Holding reported no remaining TELA Bio position as of Q1 2022 after selling out during the quarter.
  • Optiver Holding sold 4,035 TELA Bio shares in Q1 2022, an estimated $55K.
  • Optiver Holding first reported a position in TELA Bio in Q2 2021 and held it in 3 quarters.
  • Optiver Holding's TELA Bio position peaked at $65K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held TELA Bio as of Q1 2022.

Based on Optiver Holding's 13F filing for Q1 2022, filed 16 May 2022.